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The immunotoxicity of methyl isocyanate (MIC) was evaluated in female B6C3F1 mice exposed via
inhalation to 0, 1, or 3 ppm for 6 hr per day on 4 consecutive days. The antibody response to sheep
erythrocytes and natural killer cell activity were found to be unaffected by MIC exposure. Although
lymphoproliferative responses to mitogens were moderately suppressed by MIC, the differences were not
statistically significant. The response ofsplenic lymphocytes to allogeneic leukocytes in a mixedleukocyte
response (MLR) was suppressed in a dose-related fashion and was significantly different from the control
response at the 3 ppm level. This effect was thought to be secondary and a result of general toxicity,
rather than adirect effect ofMIC on the immune system. Furthermore, resistance to the infectious agents
Listeria monocytogenes, mouse malaria parasite, and influenzavirus, or to transplantable tumor cells was
not compromised by MIC exposure. Thus, the immune system does not appear to be a primary target for
MIC toxicity.
Introduction
Although the lung is recognized as the primary target
organ of methyl isocyanate (MIC), the toxicological
evaluation recently undertaken by the National Toxi-
cology Program included genetic toxicity, reproductive
toxicity, and immunotoxicity studies. Toxicity in these
organ systems could result from secondary, if not pri-
mary, effects of MIC. In order to maximize any poten-
tial of this highly reactive chemical to reach remote
tissues, the specialized studies were conducted on ani-
mals exposed subacutely. The immunotoxicity studies
reported here were composed ofselected assays for im-
mune function and host resistance following exposure
of female B6C3F1 mice to 0, 1, or 3 ppm MIC for 6 hr
periods on 4 consecutive days. With this exposure reg-
imen, 3 ppm represents approximately one-half the
LC50. No deaths occurred at3 ppm, althoughpulmonary
pathology was present. General toxicity was indicated
by the lethargic appearance of the mice following ex-
posure, a significantly decreased body weight on the
day following the last exposure, and significant de-
creases in spleen and thymus weights 7 days after the
last exposure (1). All but certain lung changes were
reversible within 28 days.
*National Toxicology Program, National Institute of Environmen-
tal Health Sciences, P. 0. Box 12233, Research Triangle Park, NC
27709.
Methods
Exposure ofAnimals
The procedure for exposure of animals to methyl is-
ocyanate (MIC) by inhalation has been described fully
(3). Exposures were conducted on 3-11 to 3-14 and 6-17
to 6-20-85. Repeated dose studies were conducted in
stainless-steel, wire-mesh exposure cages by exposing
10-week old B6C3F1 female mice 6 hr/day for 4 con-
secutive days to 0, 1, or 3 ppm MIC. During nonex-
posure periods, mice were housed in an adjacent room
on a 12 hr light cycle with food and water ad libitum.
Immunotoxicity tests were initiated within 5 days of
the last exposure.
Immune Function Assays
Humoral immunity was measured by the response to
sheep erythrocytes, a T-dependent antigen, in mice im-
munized 1 dayafterthe lastexposure. IgMplaqueform-
ing cells (PFC) were enumerated in spleen cells 4 days
later using a modified Jerne plaque assay in agar (4).
Natural killer (NK) cell activity of spleen cells was de-
termined using YAC-1 tumor target cells in a 51Cr-re-
lease assay(5). Severaleffector:target(E:T)ratioswere
used, but data are reported only from the 100:1 ratio,
which gave maximal lysis. Lymphocyte proliferation
was measured by quantitating 3H-thymidine incorpo-
ration in splenic lymphocytes responding to the T-cellTUCKER ETAL.
mitogens phytohemagglutinin (PHA) orconcanavalin A
(ConA), tothe B-cellmitogenE. colilipopolysaccharide
(LPS), and to allogeneic leukocytes (mitomycin C-
treated lymphocytes from DBA/2N mice) in a mixed
leukocyte response (MLR). Mice were sacrificed 4 days
after the last exposure for this assay. Conditions for
this assay have beenpreviouslypublished (6). Although
several concentrations ofmitogens were run, only val-
ues from optimal mitogen concentrations are reported.
Host Resistance Assays
Mice were challenged with infectious agents 5 days
after the last exposure to MIC. Resistance to bacterial
challenge with Listeria monocytogenes (strain L242/73
type 4B) was tested by IV injection of 2 x 104 viable
Table 1. Plaque-forming cell response in MIC-treated mice.
PFC/106 ceilsa
Treatmentb Experiment 1 Experiment 2
Control 1602 ± 112C 1224 ± 245
1 ppm 1420 ± 96 1698 ± 162
3 ppm 1375 ± 172 1473 ± 197
aThe antibody response to sheep erythrocytes was determined by
enumeratingplaqueformingcells(PFC)inspleniclymphocytes 4days
after primary immunization.
bSeven mice per group.
'Mean ± SEM; no values differ significantly from control.
Table 2. Natural killer (NK) cell activity in MIC-treated mice.
% Cytotoxicity'
Treatmentb Experiment 1 Experiment 2
Control 24 ± lC 14 ± 1
lppm 23±2 15±2
3ppm 20±3 16±1
'NKcytotoxicityagainst51Cr-labeled YAC-1 targetcellswasmeas-
ured at a 100:1 E:T ratio in two separate experiments. Cytotoxic
activity was calculated from the formula:
% cytotoxicity - cpmT - SR x 100
inwhich cpmE - SRis cpmof 5"Crrelease intheexperimentalminus
spontaneous release, and cpmT - SR iscpm intotal cells added (total
release) minus spontaneous release.
bSeven mice per group.
cNo values differ significantly from control.
bacteria, which approximates an LD20 in control mice.
Mortality was monitored for 14 days. A nonlethal strain
of malaria, Plasmodium yoelii 17XNL, was adminis-
tered by IV injection of 1 x 106 parasitized erythro-
cytes. The percentage of parasitized erythrocytes, de-
termined by Diff-Quik staining of tail blood, was
followed through the course ofinfection. The influenza
challenge model used was developed by IIT Research
Institute, Chicago, IL, under the direction of James
Fenters and Peter Barbera (Report L06133-5 prepared
for NIEHS contract N01-ES-1-5000). Influenza A2/Tai-
wan/64 virus was instilled intranasally, and mortality
was monitored for 14 days. Resistance to syngeneic tu-
mor cell challenge was determined by injecting 1 x 104
B16F1O tumor cells IV and determining tumor burden
in the lungs 21 days later by quantitation of 125I-iodo-
deoxyuridine (7). Host resistance data from two sepa-
rate studies was pooled for analysis.
Statistical Analysis
Data from immune function assays were analyzed by
the RS/1 multicompare procedure usingthe Wilk-Shap-
iro test fornormality, one-way analysis ofvariance, and
Dunnett's test for multiple comparison with a control.
Mortality data were analyzed by the chi-square test.
Results and Discussion
Toxicology
Based on previously reported data, mice subacutely
exposed to 3 ppm of MIC exhibited signs of toxicity
which included lethargy and decreases in body and cer-
tain organ weights, notably spleen and thymus (1). He-
matological values, determined 5 days after the last
exposure, werenormalwiththeexception ofhematocrit
values, which were slightly higher in both ofthe MIC-
exposed groups, perhaps reflecting some dehydration.
The transient nature ofthe observed effects suggested
a general rather than a specific systemic toxicological
response. However, pathologic changes in the respi-
ratory system were seen, and included erosion and ne-
crosis ofthe epithelium ofthe nasal cavity, trachea, and
bronchi, fibrosis in the walls of major bronchi, and fi-
broepithelial tissue projections into major airways (2).
Table 3. Splenic lymphocyte proliferative responses to mitogens and allogeneic leukocytes.
cpm3H-TdR (x 10-3)
Treatmenta No mitogen LPS PHA Con A MLR
Control 3.5 ± 0.7b 35.5 ± 1.4 41.7 ± 3.2 55.6 ± 5.8 18.7 ± 0.9
1 ppm 4.4 ± 1.3 25.8 ± 2.4 34.4 ± 4.7 38.3 ± 1.8 16.4 ± 0.8
(27) (18) (31) (12)
3ppm 2.5±0.6 28.6±4.3 35.5±4.3 38.9±7.3 12.7±1.0*
(29)C (19) (15) (30) (32)
aSeven mice per group.
bMean ± SEM.
cNumbers in parentheses indicate percent suppression.
*Value differs from control at p <0.05.
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Immune Function
The results of two separate experiments evaluating
the antibody response ofMIC-exposed mice are shown
in Table 1. No effect of MIC was detected on the PFC
response to sheep erythrocytes. NK cell activity from
two separate MIC exposures was also found to be un-
altered by chemical exposure (Table 2). Splenic cellu-
larity was also not altered by MIC exposure (data not
shown).
The proliferative response of splenic lymphocytes
from MIC-treated mice to B- and T-cell mitogens and
allogeneic leukocytes is shown in Table 3. There was a
trend toward suppression of the response to mitogens
in treated mice and a statistically significant depression
of the MLR at 3 ppm. A repeat study gave similar
results, with the MLR again suppressed in a dose-re-
lated fashion (data not shown). The suppression was
transient, however, as mice evaluated at the end ofthe
120-day observation period were found to be unaffected
by chemical exposure (data not shown).
Host Resistance
Following chemical exposure, groups of mice were
challenged with either Listeria monocytogenes, mouse
malaria (Plasmodium yoelli), influenza virus, or
B16F10 syngeneic tumor cells for evaluation of host
resistance. The results, representing pooled data from
the two separate exposures, are summarized in Figure
1. The Listeria and B16F10 studies included a positive
control using cyclophosphamide at 20 mg/kg, which
caused significantly impaired resistance in both cases
(data not shown). There were no statistically significant
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FIGURE 1. Effect of MIC on host resistance. The ability of mice
treated with 1 or 3 ppm ofMIC to resistbacterial, parasitic, viral,
and tumor cell challenge was compared to control mice. Following
infection with Listeria, mortality was monitored for 14 days and
is given as percentage. There were 30 mice per treatment group
in this assay. Infection with Ptasmodium is indicated by percent
parasitemia, which is the percent parasitized erythrocytes on the
peak day of infection, day 10. There were 14 mice per group in
this assay. Cumulative mortality for 14 days following infection
with influenza virus is given as percentage, and there were 35
mice pergroup. Metastasis ofB16F10tumorcells was determined
21 days after injection and is expressed as cpm '25I-iododeoxyu-
ridine in the lungs using 14 mice per treatment group. No treat-
ment values were significantly different from control in any ofthe
assays.
alterations in any of the host resistance models as a
result of MIC exposure, although there was a trend
toward susceptibility following intranasal challenge
with influenza virus. This effect may be immunological
in nature or a consequence ofimpairment oflung clear-
ance mechanisms.
In conclusion, the immune system does not appear to
be sensitive to MIC exposure in mice. The minimal
changes in immune function that were observed are
possibly a secondary consequence ofthe pulmonary or
general toxicity observed in exposed mice. In light of
the normal response of MIC-treated mice to challenge
with infectious agents and tumor cells, the immune al-
terations must be considered biologically inconsequen-
tial. Although MIC did not appear to reach primary
organs ofthe immune system, it could cause alterations
in immune function as a secondary consequence to lung
disease as has been seen in asbestosis in man (8) and in
mice (9). This aspect ofMIC toxicity was not evaluated
in the present study.
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Details of these studies have been published [Luster et al., Im-
munotoxicity studies on mice exposed to methyl isocyanate. Toxicol.
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